Skip to main content
Livermore
Livermore
ZHEN

Everett Harris & Co

SEC CIK
0001009254
Latest filing
Aug 3, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Everett Harris & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
1,452,342
Value
$131.8M
% of portfolio
1.6%
Quarters held
22
Since Q1 2021
Holdings of ABT by Everett Harris & Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,452,342$131.8M1.6%−3940.0%ReducedHolders
Q1 20261,452,736$149.2M1.9%−5,645−0.4%ReducedHolders
Q4 20251,458,381$182.7M2.2%−8,766−0.6%ReducedHolders
Q3 20251,467,147$196.5M2.4%−24,192−1.6%ReducedHolders
Q2 20251,491,339$202.8M2.6%−21,461−1.4%ReducedHolders
Q1 20251,512,800$200.7M2.6%−14,877−1.0%ReducedHolders
Q4 20241,527,677$172.8M2.2%+1,230+0.1%AddedHolders
Q3 20241,526,447$174.0M2.2%−782−0.1%ReducedHolders
Q2 20241,527,229$158.7M2.0%−3,735−0.2%ReducedHolders
Q1 20241,530,964$174.0M2.3%−14,392−0.9%ReducedHolders
Q4 20231,545,356$170.1M2.4%+2,172+0.1%AddedHolders
Q3 20231,543,184$149.5M2.3%−12,317−0.8%ReducedHolders
Q2 20231,555,501$169.6M2.6%−2,664−0.2%ReducedHolders
Q1 20231,558,165$157.8M2.6%−6050.0%ReducedHolders
Q4 20221,558,770$171.1M2.9%−1,618−0.1%ReducedHolders
Q3 20221,560,388$151.0M2.8%+3,080+0.2%AddedHolders
Q2 20221,557,308$169.2M2.9%−30,222−1.9%ReducedHolders
Q1 20221,587,530$187.9M2.7%−16,472−1.0%ReducedHolders
Q4 20211,604,002$225.7M3.1%−6,604−0.4%ReducedHolders
Q3 20211,610,606$190.3M3.0%−19,716−1.2%ReducedHolders
Q2 20211,630,322$189.0M3.0%−2,066−0.1%ReducedHolders
Q1 20211,632,388$195.6M3.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.